
Pfizer, Inc.: shareholders and insiders
Price
$28.47
November 17, 2026Market cap $162B
What Ploutos Investor adds for Pfizer
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Nov 16, 2026, from their own Form 4 filings.
Bought on the market
$3.0M
3 people
Sold on the market
$134.7K
1 person
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $3.0M by 3 people·sold $134.7K by 1 person
- 2025: no buys, no sales
- 2026: bought $3.0M by 3 people, sold $134.7K by 1 person
- Aug 12, 2026Albert BourlaChairman & CEOKind
- Aug 5, 2026Jennifer B. DamicoSVP & ControllerKind
- Aug 5, 2026Ronald E BlaylockDirectorKind
- Aug 5, 2026Mortimer J BuckleyDirectorKind
- Jun 9, 2026Jennifer B. DamicoSVP & ControllerKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Albert BourlaChairman & CEO | 38.0K | $26.34 | $1.0M | Form 4 | |
| Aug 5, 2026 | Jennifer B. DamicoSVP & Controller | 3,278 | $25.40 | $83.3K | Form 4 | |
| Aug 5, 2026 | Ronald E BlaylockDirector | 39.2K | $25.46 | $998.8K | Form 4 | |
| Aug 5, 2026 | Mortimer J BuckleyDirector | 37.6K | $25.52 | $960.4K | Form 4 | |
| Jun 9, 2026 | Jennifer B. DamicoSVP & Controller | 2,000 | $25.70 | $51.4K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade.
Insiders and their shares
Every buy and sale by PFE's officers and directors from 2006 up to November 17, 2025, 20 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 15 more, back to 2006
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Vanguard Capital ManagementShare of class7.51%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 7.51% | 427M | May 1, 2026 | 13G |
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- The Vanguard Group0.00%Mar 27, 202613G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Fairfax Financial (Watsa)In the quarter+36%
- Point72 (Cohen)In the quarter
- AQR CapitalIn the quarter+56%
- Citadel Advisors (Griffin)In the quarter-16%
- D.E. ShawIn the quarter-57%
- Renaissance TechnologiesIn the quarter
- Bridgewater (Dalio)In the quarter
- Millennium Mgmt (Englander)In the quarter+477%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Fairfax Financial (Watsa) | 1.42M | +36% | $40M | 1.53% |
| Point72 (Cohen) | – | – | 0.21% | |
| AQR Capital | 18.56M | +56% | $445M | 0.16% |
| Citadel Advisors (Griffin) | 6.19M | -16% | $149M | 0.09% |
| D.E. Shaw | 5.41M | -57% | $130M | 0.08% |
| Renaissance Technologies | 1.99M | $57M | 0.08% | |
| Bridgewater (Dalio) | 180.1K | $4.3M | 0.02% | |
| Millennium Mgmt (Englander) | 556.1K | +477% | $13M | 0.01% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 2.42% of its shares outstanding were held short, -8.3% since the report before.
- Shares held short
- 138M
- 2.42%
- Since the report before150M on Sep 30, 2026
- -8.3%
- 4.5
- 30.83M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 54%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 47.18M
- Nov 15, 2023: Shares held short 57.50M
- Nov 30, 2023: Shares held short 56.94M
- Dec 15, 2023: Shares held short 61.89M
- Dec 29, 2023: Shares held short 57.03M
- Jan 12, 2024: Shares held short 57.58M
- Jan 31, 2024: Shares held short 60.19M
- Feb 15, 2024: Shares held short 60.68M
- Feb 29, 2024: Shares held short 66.12M
- Mar 15, 2024: Shares held short 71.65M
- Mar 28, 2024: Shares held short 65.00M
- Apr 15, 2024: Shares held short 68.06M
- Apr 30, 2024: Shares held short 62.51M
- May 15, 2024: Shares held short 70.22M
- May 31, 2024: Shares held short 75.97M
- Jun 14, 2024: Shares held short 62.07M
- Jun 28, 2024: Shares held short 59.89M
- Jul 15, 2024: Shares held short 55.70M
- Jul 31, 2024: Shares held short 65.33M
- Aug 15, 2024: Shares held short 61.73M
- Aug 30, 2024: Shares held short 65.38M
- Sep 13, 2024: Shares held short 74.84M
- Sep 30, 2024: Shares held short 67.62M
- Oct 15, 2024: Shares held short 70.94M
- Oct 31, 2024: Shares held short 61.87M
- Nov 15, 2024: Shares held short 94.54M
- Nov 29, 2024: Shares held short 90.38M
- Dec 13, 2024: Shares held short 85.37M
- Dec 31, 2024: Shares held short 75.71M
- Jan 15, 2025: Shares held short 91.78M
- Jan 31, 2025: Shares held short 73.57M
- Feb 14, 2025: Shares held short 89.12M
- Feb 28, 2025: Shares held short 94.96M
- Mar 14, 2025: Shares held short 99.17M
- Mar 31, 2025: Shares held short 97.49M
- Apr 15, 2025: Shares held short 107M
- Apr 30, 2025: Shares held short 115M
- May 15, 2025: Shares held short 107M
- May 30, 2025: Shares held short 105M
- Jun 13, 2025: Shares held short 107M
- Jun 30, 2025: Shares held short 112M
- Jul 15, 2025: Shares held short 99.27M
- Jul 31, 2025: Shares held short 108M
- Aug 15, 2025: Shares held short 114M
- Aug 29, 2025: Shares held short 103M
- Sep 15, 2025: Shares held short 113M
- Sep 30, 2025: Shares held short 114M
- Oct 15, 2025: Shares held short 117M
- Oct 31, 2025: Shares held short 127M
- Nov 14, 2025: Shares held short 131M
- Nov 28, 2025: Shares held short 139M
- Dec 15, 2025: Shares held short 139M
- Dec 31, 2025: Shares held short 130M
- Jan 15, 2026: Shares held short 130M
- Jan 30, 2026: Shares held short 143M
- Feb 13, 2026: Shares held short 146M
- Feb 27, 2026: Shares held short 143M
- Mar 13, 2026: Shares held short 131M
- Mar 31, 2026: Shares held short 132M
- Apr 15, 2026: Shares held short 133M
- Apr 30, 2026: Shares held short 140M
- May 15, 2026: Shares held short 157M
- May 29, 2026: Shares held short 163M
- Jun 15, 2026: Shares held short 162M
- Jun 30, 2026: Shares held short 164M
- Jul 15, 2026: Shares held short 164M
- Jul 31, 2026: Shares held short 161M
- Aug 14, 2026: Shares held short 149M
- Aug 31, 2026: Shares held short 152M
- Sep 15, 2026: Shares held short 155M
- Sep 30, 2026: Shares held short 150M
- Oct 15, 2026: Shares held short 138M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading37.7% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 37.7% of the shares in the reported trades were short sales, against 45.0% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 37.7%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 45.0%
- Change
- -7.3 pts
- Short sales a dayon average, of 14.28M shares
- 5.38M
- More than atof 3,666 US-listed companies, same days
- 15%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 43.7%
- Oct 12, 2026: Short sales 64.3%
- Oct 13, 2026: Short sales 56%
- Oct 14, 2026: Short sales 43.8%
- Oct 15, 2026: Short sales 42.8%
- Oct 16, 2026: Short sales 36.8%
- Oct 19, 2026: Short sales 43.7%
- Oct 20, 2026: Short sales 36.4%
- Oct 21, 2026: Short sales 44.2%
- Oct 22, 2026: Short sales 35.9%
- Oct 23, 2026: Short sales 43.6%
- Oct 26, 2026: Short sales 61.2%
- Oct 27, 2026: Short sales 45.7%
- Oct 28, 2026: Short sales 39.1%
- Oct 29, 2026: Short sales 36.7%
- Oct 30, 2026: Short sales 38.4%
- Nov 2, 2026: Short sales 40.7%
- Nov 3, 2026: Short sales 36%
- Nov 4, 2026: Short sales 29.2%
- Nov 5, 2026: Short sales 43.2%
- Nov 6, 2026: Short sales 37%
- Nov 9, 2026: Short sales 40.9%
- Nov 10, 2026: Short sales 35.1%
- Nov 11, 2026: Short sales 39.3%
- Nov 12, 2026: Short sales 48.5%
- Nov 13, 2026: Short sales 33.8%
- Nov 16, 2026: Short sales 40.3%
- Nov 17, 2026: Short sales 29.3%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Albert BourlaChairman & CEODirectly429.2K
- Ronald E BlaylockDirectorDirectly66.9K
- Mortimer J BuckleyDirectorDirectly37.6K
- Jennifer B. DamicoSVP & ControllerDirectly28.6K
- Scott GottliebDirectorDirectly10.0K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Albert BourlaChairman & CEO | 429.2K | – | Aug 12, 2026 | Form 4 |
| Ronald E BlaylockDirector | 66.9K | – | Aug 5, 2026 | Form 4 |
| Mortimer J BuckleyDirector | 37.6K | – | Aug 5, 2026 | Form 4 |
| Jennifer B. DamicoSVP & Controller | 28.6K | – | Aug 5, 2026 | Form 4 |
| Scott GottliebDirector | 10.0K | – | Oct 30, 2024 | Form 4 |
A lower bound: it counts only the 5 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
Executive pay
From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.
$28M
Actually paid: $34M
$9.6M
Actually paid: $11M
$86
Peers: $187
Adjusted Net Income
$19.3B
From the proxy statement (DEF 14A) of Mar 12, 2026, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A
Share repurchases
How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.
- Apr 3, 202210-QAmount$2.6B
| Quarter | Shares | Average price | Amount | Left in the program | Filing |
|---|---|---|---|---|---|
| Apr 3, 202210-Q | 51.25M | $50.12 | $2.6B | $3.3B | 10-Q |
From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price. 22 filing(s) not shown, as the table was not read or did not agree with the cash.
The shareholders' vote on pay
The advisory say-on-pay vote at each annual meeting, as the company states it in the 8-K it files after the meeting: how many voted for and against the executives' pay. 90% is the norm. Under 70% proxy advisers expect the board to respond the next year.
- 2026Apr 27, 2026For88.0%
- 2025Apr 28, 2025For54.7%
- 2024Apr 29, 2024For91.4%
- 2023May 1, 2023For92.8%
- 2022May 2, 2022For92.7%
- 2021Apr 26, 2021For92.8%
| Year | For | Votes for | Votes against | Abstentions | Broker non-votes | Filing |
|---|---|---|---|---|---|---|
| 2026Apr 27, 2026 | 88.0% | 3.10B | 424M | 33.44M | 941M | 8-K |
| 2025Apr 28, 2025 | 54.7% | 1.95B | 1.61B | 21.90M | 955M | 8-K |
| 2024Apr 29, 2024 | 91.4% | 3.36B | 315M | 26.26M | 893M | 8-K |
| 2023May 1, 2023 | 92.8% | 3.58B | 279M | 27.82M | 823M | 8-K |
| 2022May 2, 2022 | 92.7% | 3.51B | 275M | 25.06M | 850M | 8-K |
| 2021Apr 26, 2021 | 92.8% | 3.36B | 259M | 31.35M | 872M | 8-K |
From the 8-K (item 5.07) the company files after each annual meeting since 2021, read from the filing's text without a model. A company that votes every three years has empty years. The vote is advisory: the board is not bound by it.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- FDLFirst Trust Morningstar Dividend Leaders Index FundWeight in the fund5.91%
- PPHVanEck Pharmaceutical ETFWeight in the fund4.51%
- HDViShares Core High Dividend ETFWeight in the fund4.27%
- IHEiShares U.S. Pharmaceuticals ETFWeight in the fund3.96%
- SPHDInvesco S&P 500 High Dividend Low Volatility ETFWeight in the fund3.41%
- XLVState Street(R) Health Care Select Sector SPDR(R) ETFWeight in the fund2.39%
- IYHiShares U.S. Healthcare ETFWeight in the fund2.35%
- VHTVanguard Health Care Index FundWeight in the fund2.24%
- DVYiShares Select Dividend ETFWeight in the fund2.00%
- COWZPacer US Cash Cows 100 ETFWeight in the fund1.84%
64 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 2,821
- Q4 2025: Managers 2,922
- Q1 2026: Managers 2,962
- Q2 2026: Managers 2,829
Institutional investors by quarter
The fund managers holding PFE, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 2,829 managers held 3.83B shares, worth $92.3B. During the quarter 152 opened a position, 285 closed one, 1,122 added and 1,194 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+6.3%
- Vanguard Capital ManagementIn the quarter+0.7%
- State StreetIn the quarter+1.8%
- Geode Capital ManagementIn the quarter+1.3%
- Vanguard Portfolio ManagementIn the quarter+2.1%
- Fisher Asset ManagementIn the quarter+3.9%
- Morgan StanleyIn the quarter+3.9%
- Norges BankIn the quarter-16%
- Northern TrustIn the quarter-4.7%
- Bank of New York MellonIn the quarter+7.4%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 530M | +6.3% | $12.8B |
| Vanguard Capital Management | 372M | +0.7% | $9.0B |
| State Street | 307M | +1.8% | $7.4B |
| Geode Capital Management | 135M | +1.3% | $3.2B |
| Vanguard Portfolio Management | 119M | +2.1% | $2.9B |
| Fisher Asset Management | 109M | +3.9% | $2.6B |
| Morgan Stanley | 96.35M | +3.9% | $2.3B |
| Norges Bank | 61.51M | -16% | $1.5B |
| Northern Trust | 59.08M | -4.7% | $1.4B |
| Bank of New York Mellon | 57.88M | +7.4% | $1.4B |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
The full analysis
What do Pfizer's filings show?
Who buys and sells is one part of Pfizer's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have PFE's insiders bought or sold?
From Jun 1, 2026 to Nov 16, 2026 Pfizer's insiders bought $3.0M and sold $134.7K of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold PFE?
8 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $445M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.